A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations
- PMID: 25719932
- PMCID: PMC4422885
- DOI: 10.1210/jc.2014-4352
A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations
Abstract
Context: Antibodies against thyroid peroxidase (TPOAbs) are detected in 90% of all patients with Hashimoto thyroiditis, the most common cause of hypothyroidism. Hypothyroidism is associated with a range of adverse outcomes. The current knowledge of its genetic underpinnings is limited.
Objective: The purpose of this study was to identify novel genetic variants associated with TPOAb concentrations and positivity using genome-wide association data and to characterize their association with thyroid function and disease.
Design, setting, and participants: We studied European ancestry participants of 3 independent prospective population-based studies: Atherosclerosis Risk In Communities study (n = 7524), Study of Health in Pomerania (n = 3803), and Study of Health in Pomerania-TREND (n = 887).
Exposure: Single nucleotide polymorphisms (SNPs), individually and combined into a genetic risk score (GRS), were examined.
Main outcomes: The main outcomes were TPOAb concentrations and positivity, thyroid hormone concentrations (TSH, free T4), and clinical thyroid diseases (subclinical and overt hypothyroidism and goiter).
Results: Significantly associated single nucleotide polymorphisms (P < 5 · 10(-8)) mapped into 4 genomic regions not previously implicated for TPOAbs (RERE, extended HLA region) and into 5 previously described loci. A higher Genetic Risk Score (GRS) based on these 9 SNPs showed strong and graded associations with higher TPOAb, TSH, and lower free T4 concentrations (P < .001). Compared with individuals in the lowest GRS quartile, those in the highest quartile had 1.80-fold higher odds of subclinical hypothyroidism (95% confidence interval, 1.27-2.55) and 1.89-fold higher odds of overt hypothyroidism (95% confidence interval, 1.24-2.87).
Conclusion: The identification of 4 novel genetic loci associated with TPOAb concentrations and positivity gives further insight into the genetic underpinnings of hypothyroidism. A GRS showed strong and graded associations with markers of thyroid function and disease in independent population-based studies.
Figures
References
-
- Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29:76–131. - PubMed
-
- Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012;379:1142–1154. - PubMed
-
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18:988–1028. - PubMed
-
- Roberts CG, Ladenson PW. Hypothyroidism. Lancet. 2004;363:793–803. - PubMed
-
- Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228–238. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HHSN268201100012C/HL/NHLBI NIH HHS/United States
- UL1RR025005/RR/NCRR NIH HHS/United States
- R01HL59367/HL/NHLBI NIH HHS/United States
- HHSN268201100010C/HL/NHLBI NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- HHSN268201100005G/HL/NHLBI NIH HHS/United States
- HHSN268201100008I/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/PHS HHS/United States
- R01 DK089174/DK/NIDDK NIH HHS/United States
- R01 HL059367/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- R01DK089174/DK/NIDDK NIH HHS/United States
- HHSN268201100011I/HL/NHLBI NIH HHS/United States
- HHSN268201100011C/HL/NHLBI NIH HHS/United States
- R01 HL086694/HL/NHLBI NIH HHS/United States
- HHSN268200625226C/PHS HHS/United States
- U01 HG004402/HG/NHGRI NIH HHS/United States
- HSN268201100006C/PHS HHS/United States
- HHSN268201100010C/PHS HHS/United States
- U01HG004402/HG/NHGRI NIH HHS/United States
- HHSN268201100008C/PHS HHS/United States
- HHSN268201100012C/PHS HHS/United States
- R01HL087641/HL/NHLBI NIH HHS/United States
- HHSN268201100005I/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/PHS HHS/United States
- HHSN268201100011C/PHS HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
- HHSN268201100007I/HL/NHLBI NIH HHS/United States
- R01 HL087641/HL/NHLBI NIH HHS/United States
- HSN268201100009C/PHS HHS/United States
- R01HL086694/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
